This award will fund clinical, basic, translational, and population health projects that seek to better understand the pathobiology and clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19 : a new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention; development of novel therapeutics and vaccines; understanding host factors that alter response to these infections; understanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses; and case tracking and epidemiological approaches. Grants are up to $200,000 over two years; proposals are due by May 30, 2020.
American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award
Sponsor or Type
Deadline
May 30, 2020